%0 Journal Article
%A Martinez-Montoro, Jose Ignacio
%A Pinzon-Martín, Jose Luis
%A Damas-Fuentes, Miguel
%A Fernandez-Valero, Andrea
%A Tinahones, Francisco J
%T Combination Therapy With Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report.
%D 2022
%@ 1664-2392
%U http://hdl.handle.net/10668/20559
%X Type A insulin resistance (IR) syndrome is a very uncommon genetic disorder affecting the insulin receptor (INSR) gene, characterized by severe IR without the presence of obesity. Patients with this condition will eventually develop diabetes, presenting a variable response to insulin-sensitizers, such as metformin and thiazolidinediones, and high doses of insulin. We report for the first time the results of the use of combination therapy with a glucagon-like peptide-1 receptor agonist and a sodium-glucose cotransporter 2 inhibitor for the treatment of diabetes in the context of type A IR syndrome.
%K Type A insulin resistance syndrome
%K diabetes
%K glucagon-like peptide-1 receptor agonist
%K insulin resistance
%K sodium-glucose cotransporter 2 inhibitor
%~